Technology Companies

Brian Goldstein, John Meltaus, Bob Jahrling, David Brown, Bill Asher, Larry Naughton, Karen Copenhaver

Blue Chip Clients

Lawyers have represented blue chip clients, including:

Astellas Pharma
Avid Technology
Bayer
Citrix Systems
Dana Farber
Eisai
General Electric
Haemonetics
Harvard  
Hewlett-Packard
Linux Foundation
Mass General Hospital
Memorial Sloan-Kettering
MIT
Pegasystems
Raytheon
Research in Motion
SeaChange International
Sierra Pacific
Stanford
Teradyne
Vertex Pharmaceuticals
Wyeth/Pfizer

Capital Markets Leader

Lawyers have represented blue chip investment bankers and underwriters, including:

Bank of America Merrill Lynch
Canaccord Genuity
Deutsche Bank
JP Morgan Chase
Morgan Stanley
Needham & Co.
SG Cowen Securities
Stifel Nicolaus Weisel
UBS Securities
William Blair

Experts in Industry Partnerships

Lawyers have negotiated key strategic partnerships, licenses, joint ventures, distributorships and commercial transactions with industry leaders, including:

Alcatel
Baxter Healthcare  
Becton, Dickinson
Cisco  
Comcast  
Dow Chemicals  
IBM    
Intel  
Monsanto  
Nortel  
Oracle  
Pfizer  
Pharmacia

  • toggle

    Over one-third of equity partners and majority of practice areas recognized for excellence

  •  
    toggle
    Rees Hawkins Named to “40 Under 40” List by M&A Advisor

    Rees Hawkins has been selected as one of The M&A Advisor’s 40 Under 40 Award Winners in the Legal Advisor category.  Read more...

  • Choate received The M&A Advisor’s “Financial Services Deal of the Year” award in the over $200 million category.  Read more…

  •  
    toggle
    Karen Copenhaver Named 2013 Top Woman of Law

    Karen Copenhaver has been named a “Top Woman of Law” by Massachusetts Lawyers Weekly for her accomplishments in the legal community.  Read more...

  • legalTV
  • Over 70% of equity partners named Best in America by Best LawyersRead more...

 

Business & Technology

"this is a team that places a real emphasis on relationships; clients of all sizes enthused about the attention they received and likened the relationships to those with in-house counsel"

Chambers USA

Experts in Technology & Life Sciences

Representing leading technology and life sciences companies in their entire life cycle from start-up to public company to M&A.

Premier Venture Capital Practice

Represent investors and emerging companies in full range of venture financings across industries, geographies, and investment strategies.  Read more...

Experts in Mergers & Acquisitions

Expert representation of acquirers, targets, financing sources and investment bankers in public and private mergers and acquisitions, domestic and international.  Read more...

Transaction Powerhouse

  • Mergers and acquisitions with value over $55 billion.
  • Public company securities offerings with proceeds of over $18 billion.
  • Private placements with proceeds over $3.6 billion.
    (since 2000)

IP – Maximizing Value

Lawyers with PhDs and other advanced degrees perform cutting edge work and strategic planning in technology and life sciences.  One of first major Boston firms to establish patent group.  Nationally recognized IP litigation practice.  Read more...

World-Class Licensing Capability

Among most experienced and knowledgeable licensing lawyers in US in all areas including open source.

National/International Reach

Technology and life sciences company transactions in almost all 50 states and many foreign countries, especially in Europe, Asia and the Middle East.  Preeminent US – Canada cross-border practice.

National Recognition

  • Ranked among the top “Most Active Law Firms” worldwide based on number of private equity and venture capital deals negotiated and closed in 2012 (Private Equity Analyst)
  • Ranked nationally among the top law firms in the US for Middle-Market M&A and Venture Capital and Emerging Companies (The Legal 500, guide to the preeminent law firms in US)
  • Ranked among the top “Most Active Law Firms” worldwide based on number of private equity and venture capital funds worked on for general partners and limited partners that closed in 2012 (Private Equity Analyst)
 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline